Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M573Revenue (TTM) $M212Net Margin (%)6.3Altman Z-Score2.4
Enterprise Value $M663EPS (TTM) $0.3Operating Margin %15.0Piotroski F-Score5
P/E(ttm)43.1Beneish M-Score1.3Pre-tax Margin (%)8.0Higher ROA y-yN
Price/Book4.010-y EBITDA Growth Rate %--Quick Ratio3.2Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow25.9y-y EBITDA Growth Rate %72.9ROA % (ttm)3.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)11.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M45.8ROIC % (ttm)14.5Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SCMPJoel Greenblatt 2016-06-30 Sold Out -0.03%$10.09 - $12.42
($11.19)
$ 12.5012%Sold Out0
SCMPJoel Greenblatt 2016-03-31 Reduce-0.06%$9.84 - $17.29
($12.7)
$ 12.50-2%Reduce -51.23%284,704
SCMPJoel Greenblatt 2015-12-31 Add0.08%$15.56 - $21.48
($17.91)
$ 12.50-30%Add 273.69%583,716
SCMPJoel Greenblatt 2015-09-30 Reduce-0.03%$16.34 - $28.96
($22.93)
$ 12.50-45%Reduce -53.28%156,205
SCMPJoel Greenblatt 2015-06-30 Add0.03%$14.5 - $21.75
($17.31)
$ 12.50-28%Add 222.92%334,346
SCMPJoel Greenblatt 2015-03-31 Buy 0.01%$13.12 - $18.56
($15.5)
$ 12.50-19%New holding103,538
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SCMP is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Greenleaf PeterCEO 2016-11-29Sell200,000$16.84-25.77view
Getman Daniel PDirector 2016-11-29Sell20,000$16.86-25.86view
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec. 2016-11-28Sell150,000$16-21.88view
Smith Andrew PCFO 2016-11-15Sell1,766$15.58-19.77view
Smith Andrew PCFO 2015-11-16Buy1,605$17.03-26.6view
Getman Daniel PDirector 2015-08-28Sell30,000$28.14-55.58view
Knapp Thomas JFormer Officer 2015-07-20Sell64,528$23.43-46.65view
Kuno Sachiko10% Owner 2015-03-31Sell1,600,000$14-10.71view
S&R Technology Holdings, LLC10% Owner 2015-03-31Sell1,186,113$14-10.71view
Ueno Ryuji10% Owner 2015-03-31Sell1,600,000$14-10.71view

Quarterly/Annual Reports about SCMP:

News about SCMP:

Articles On GuruFocus.com
NeoPhotonics Delivers Sustained Profitability; Gevo Continues Biofuel Deal Momentum May 08 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 07 2009 

More From Other Websites
4 Profitable Stocks with Amazingly High Returns Jan 16 2017
5 Top Ranked Stocks with Upgraded Broker Ratings to Buy Now Jan 16 2017
Coherus Offers Positive Phase III Data on Humira Biosimilar Jan 13 2017
TherapeuticsMD's Rejoice Study Data Published in Journal Jan 12 2017
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Insulet, Western Refining, PennyMac... Jan 11 2017
5 Underperformers of 2016: Turnaround Story in 2017? Jan 10 2017
Zacks.com featured highlights: NVIDIA, Sucampo Pharmaceuticals, Calavo Growers, Tucows and E*TRADE... Jan 10 2017
Go Driehaus Way: 5 Momentum Picks Jan 09 2017
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 09 2017
Top Ranked Growth Stocks to Buy for January 6th Jan 06 2017
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin... Jan 04 2017
Why Sucampo Pharmaceuticals (SCMP)Could Be an Impressive Growth Stock Jan 04 2017
3 Overlooked Drug Stocks to Watch Out for in 2017 Jan 03 2017
Zacks.com featured highlights: Calavo Growers, Cytokinetics, Sucampo Pharmaceuticals, State National... Dec 29 2016
5 Profitable Stocks to Buy for Great Returns Dec 28 2016
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Dec 27 2016
Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up Dec 27 2016
4 Top Stocks with Earnings Acceleration to Buy in 2017 Dec 27 2016
Ironwood, Allergan Report Positive Linzess IBS-C Study Data Dec 23 2016
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Its New Debt Offering Of Convertible Notes Dec 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)